Pulmonary thrombosis in 2019-nCoV pneumonia?
作者信息
Marongiu Francesco, Grandone Elvira, Barcellona Doris
机构信息
Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Atherosclerosis and Thrombosis Unit, IRCCS Ospedale Casa Sollievo della Sofferenza, Foggia, Italy.
出版信息
J Thromb Haemost. 2020 Jun;18(6):1511-1513. doi: 10.1111/jth.14818. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Pulmonary thrombosis in 2019-nCoV pneumonia?2019新型冠状病毒肺炎中的肺血栓形成？
J Thromb Haemost. 2020 Jun;18(6):1511-1513. doi: 10.1111/jth.14818. Epub 2020 Apr 15.
2
Response to 'Pulmonary thrombosis in 2019-nCoV pneumonia?'.对“2019新型冠状病毒肺炎中的肺血栓形成？”的回应
J Thromb Haemost. 2020 Jun;18(6):1513-1514. doi: 10.1111/jth.14843. Epub 2020 May 12.
3
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia.2019新型冠状病毒肺炎患者的弥散性血管内凝血
J Thromb Haemost. 2020 Apr;18(4):786-787. doi: 10.1111/jth.14781. Epub 2020 Mar 24.
4
Covid-19, Angiogenesis, and ARDS Endotypes.新型冠状病毒肺炎、血管生成与急性呼吸窘迫综合征的内型
N Engl J Med. 2020 Jul 9;383(2):182-183. doi: 10.1056/NEJMe2018629. Epub 2020 May 21.
5
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
6
DIC in COVID-19: Implications for prognosis and treatment?新型冠状病毒肺炎中的弥散性血管内凝血：对预后和治疗的影响？
J Thromb Haemost. 2020 Jul;18(7):1798-1799. doi: 10.1111/jth.14878. Epub 2020 Jun 14.
7
Pulmonary Vascular Pathology in Covid-19.新冠病毒肺炎中的肺血管病理学
N Engl J Med. 2020 Aug 27;383(9):886-887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
8
What to do next to control the 2019-nCoV epidemic?接下来要采取什么措施来控制2019新型冠状病毒疫情？
Lancet. 2020 Feb 8;395(10222):391-393. doi: 10.1016/S0140-6736(20)30300-7.
9
Pulmonary Vascular Pathology in Covid-19.新型冠状病毒肺炎中的肺血管病理学
N Engl J Med. 2020 Aug 27;383(9):887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
10
Pulmonary Vascular Pathology in Covid-19.新型冠状病毒肺炎中的肺血管病理学
N Engl J Med. 2020 Aug 27;383(9):887-888. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
引用本文的文献
1
Is anticoagulative therapy in systemic sclerosis to be reconsidered?系统性硬化症的抗凝治疗是否应重新考虑？
J Scleroderma Relat Disord. 2024 Jun;9(2):81-85. doi: 10.1177/23971983241256250. Epub 2024 Jun 19.
2
Emerging patterns of hypercoagulability associated with critical COVID-19: A review.与重症新型冠状病毒肺炎相关的高凝状态新趋势：综述
Trends Anaesth Crit Care. 2020 Oct;34:4-13. doi: 10.1016/j.tacc.2020.07.004. Epub 2020 Jul 9.
3
A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis.系统性硬皮病血管病变之旅：聚焦止血和血栓形成。
Clin Exp Med. 2023 Dec;23(8):4057-4064. doi: 10.1007/s10238-023-01222-x. Epub 2023 Nov 1.
4
Investigation of Pulmonary Artery and Ascending Aorta Morphology in the Coronavirus Disease 2019: A Radioanatomical Study.2019冠状病毒病中肺动脉和升主动脉形态学研究：一项放射解剖学研究
Thorac Res Pract. 2023 Jan;24(1):40-44. doi: 10.5152/ThoracResPract.2023.22107.
5
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.2019冠状病毒病与 Janus 激酶（JAK）通路抑制的潜力：一种新的治疗策略。
Front Med (Lausanne). 2022 Aug 30;9:961027. doi: 10.3389/fmed.2022.961027. eCollection 2022.
6
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.新冠疫情与肥胖症双重大流行：双向影响
Diabetes Ther. 2022 Oct;13(10):1723-1736. doi: 10.1007/s13300-022-01311-2. Epub 2022 Aug 27.
7
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.新型冠状病毒肺炎相关急性呼吸窘迫综合征中溶栓药物的药物治疗考量
J Intensive Care. 2022 Jul 30;10(1):38. doi: 10.1186/s40560-022-00625-4.
8
The impact of daily troponin I and D-dimer serum levels on mortality in COVID-19 pneumonia patients.新型冠状病毒肺炎患者血清肌钙蛋白 I 和 D-二聚体水平对死亡率的影响。
Cardiovasc J Afr. 2023;34(1):16-22. doi: 10.5830/CVJA-2022-017. Epub 2022 May 16.
9
Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission.住院时 SARS-CoV-2 PCR 阳性和阴性患者的止血差异。
PLoS One. 2022 Apr 28;17(4):e0267605. doi: 10.1371/journal.pone.0267605. eCollection 2022.
10
The association between the CT severity index and the pulmonary artery area in COVID-19 pneumonia.新冠病毒肺炎中CT严重程度指数与肺动脉面积之间的关联。
Acta Radiol. 2023 Jul;64(7):2238-2244. doi: 10.1177/02841851211070491. Epub 2022 Jan 24.
本文引用的文献
1
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
2
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
3
Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis.急性呼吸窘迫综合征作为血管微血管血栓性疾病的器官表型：基于止血理论和内皮分子发病机制。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619887437. doi: 10.1177/1076029619887437.
4
Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis.磺达肝癸钠五聚糖可减少脓毒症凝血障碍并提高大肠杆菌败血症狒狒模型的存活率。
J Thromb Haemost. 2020 Jan;18(1):180-190. doi: 10.1111/jth.14642. Epub 2019 Oct 16.
5
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism?肺血栓栓塞症：一种与肺栓塞不同的临床病理实体？
Semin Thromb Hemost. 2019 Nov;45(8):778-783. doi: 10.1055/s-0039-1696942. Epub 2019 Sep 19.
6
Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia-derived sepsis.在肺炎相关性脓毒症中抑制外源性或内源性凝血途径。
Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L799-L809. doi: 10.1152/ajplung.00014.2018. Epub 2018 Aug 23.
7
The role of mononuclear phagocytes in Ebola virus infection.单核吞噬细胞在埃博拉病毒感染中的作用。
J Leukoc Biol. 2018 Oct;104(4):717-727. doi: 10.1002/JLB.4RI0518-183R. Epub 2018 Aug 10.
8
The coagulation system in host defense.宿主防御中的凝血系统。
Res Pract Thromb Haemost. 2018 May 24;2(3):549-557. doi: 10.1002/rth2.12109. eCollection 2018 Jul.
9
Pathogenesis and diagnosis of disseminated intravascular coagulation.弥散性血管内凝血的发病机制与诊断。
Int J Lab Hematol. 2018 May;40 Suppl 1:15-20. doi: 10.1111/ijlh.12830.
10
Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir.病例报告：一名免疫功能正常的成年人发生严重巨细胞病毒原发性感染并伴有弥散性血管内凝血，接受缬更昔洛韦治疗。
BMC Infect Dis. 2016 Jan 19;16:19. doi: 10.1186/s12879-016-1343-3.
Zotero 插件